Nephros, Inc. (NEPH)
3.91
-0.09
(-2.25%)
USD |
NASDAQ |
Feb 27, 16:00
3.88
-0.03
(-0.77%)
After-Hours: 20:00
Nephros Research and Development Expense (TTM) : 1.196M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Apyx Medical Corp. | 3.546M |
| Cerus Corp. | 66.77M |
| Owlet, Inc. | 12.94M |
| Abbott Laboratories | 2.89B |
| Plus Therapeutics, Inc. | 7.624M |